Background: Disease maps are an important tool in cancer epidemiology used for the analysis of geographical variations in disease rates and the investigation of environmental risk factors underlying spatial patterns. Cancer maps help epidemiologists highlight geographic areas with high and low prevalence, incidence, or mortality rates of cancers, and the variability of such rates over a spatial domain. They can also be used to detect "hot-spots" or spatial clusters which may arise due to common environmental, demographic, or cultural effects shared by neighboring regions. Statistical methods for spatial data formulate models to capture spatial autocorrelation and produce cancer maps to better detect clustering and hotspots. When more than one cancer is of interest, the models must also capture the inherent or endemic association between the diseases in addition to the spatial association. This article develops interpretable and easily implementable spatial autocorrelation models for two or more cancers.
Introduction
Disease mapping, which refers to techniques for mapping and analysis of geographical variations in disease rates and the investigation of environmental risk factors underlying these patterns, has long been an important tool in cancer epidemiology (1) . Disease maps are used to highlight geographic areas with high and low prevalence, incidence, or mortality rates of cancers, and the variability of such rates over a spatial domain. They can also be used to detect "hot-spots" or spatial clusters which may arise due to common environmental, demographic, or cultural effects shared by neighboring regions. Maps of crude incidence or mortality rates can be misleading when the population sizes for some of the units are small, which results in large variability in the estimated rates, and makes it difficult to distinguish chance variability from genuine differences. The correct geographic allocation of health care resources can be greatly enhanced by deployment of statistical models that allow a more accurate depiction of true disease rates and their relation to explanatory variables (covariates). Many tasks critical for successful cancer surveillance and control require new inferential methods to handle these complex and often spatially indexed data sets. Since local sample sizes within each spatial region are too low for design-based solutions to attain desired levels of statistical precision (2) , much recent work in disease-mapping has been carried out within the context of Bayesian hierarchical models (3) . The body of scientific literature on modern methods for geographic disease mapping is too vast to be reviewed here. Comprehensive reviews of prevalent statistical disease mapping methods and their implementation using available software can be found, among several other sources (4, 5, 6, 7) .
Statistical models for mapping a single disease have employed probability distributions such as Markov random fields or MRFs (8) that introduce dependence using the adjacency information among the different regions on a map. Two popular examples are the Conditional Autoregression (CAR) and Simultaneous Autoregression (SAR) models (9, 10, 11, 12) for further discussions on CAR and SAR models. More recently, Directed Acyclic Graphical Autoregressive (DAGAR) models that employ directed acyclic graphs have been developed as a preferred alternative to CAR or SAR models (13) . A specific motivation for DAGAR models is that they impart greater interpretability to the spatial autocorrelation parameter.
In this article, we will perform joint spatial mapping of two different types of cancers. Joint modeling is appropriate when different diseases have been observed over the same spatial units and when the diseases themselves are related to each other, say because they share the same set of spatially distributed risk factors or the presence of one disease in a spatial unit may encourage or inhibit the presence of the second disease in the same spatial unit. Put differently, we seek models to capture the spatial association for each disease as well as the association between the diseases. There is, by now, a substantial literature on multivariate disease mapping (14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24) . These articles have demonstrated, theoretically and empirically, the benefits of jointly modeling several potentially related cancers, as opposed to modeling them independently. While it has been assertively demonstrated that independent models for cancers can lead to biased results because of unaccounted associations among the cancers, the current literature is largely based on using CAR models for spatial mapping. Our proposed bivariate DAGAR model for modeling two diseases over the same spatial region will help epidemiologists and spatial analysts better interpret the association among the cancers.
The balance of this article proceeds by developing a class of bivariate DAGAR models, conducting some disease mapping for two different cancers, and summarizing with some concluding remarks.
Methods
Our approach will be to construct a probability model for each disease using the distribution specified by DAGAR.
We will extend the univariate DAGAR to a bivariate model by modeling the distribution of one disease as a univariate DAGAR and the conditional distribution of the second disease given the first also as a DAGAR. In this sense, our bivariate DAGAR is analogous to the bivariate CAR models (19) . We develop notations and briefly discuss the univariate DAGAR in the next section, followed by the bivariate extension in the following section.
DAGAR for modeling a single disease
We consider a geographic map of our region of interest (e.g., a particular state) delineated by k distinct administrative regions (e.g., counties or ZIP codes) with clear boundaries separating them. Let w = (w 1 , w 2 , . . . , w k ) be a k × 1 vector consisting of spatially associated random effects corresponding to each region. We develop a spatially correlated model using a directed acyclic graph. The geographic map provides us with a list of neighbors for each region.
Neighbors can be defined by the user. Common definitions include when two regions share a common boundary or if their centers are within a certain fixed distance, although the model and resulting distribution theory hold for any fixed set of neighbors. The data structure for the geographic map and its neighbors is defined as a graph, denoted G = {V, E}, where the regions are indexed by an ordered set V = {1, 2, . . . , k} and form the vertices of the graph and E is the collection of edges between the vertices, i.e., the collection of ordered pairs (j, j ) such that j and j are geographic neighbors based upon some specified definition.
The DAGAR model specifies w ∼ N (0, τ Q(ρ)), where Q(ρ) is a spatial precision matrix that depends only upon a spatial autocorrelation parameter ρ and τ is a positive scale parameter. To describe Q(ρ), we define neighbor sets
the set V excluding the region indexed by 1, and j ∈ V.
Thus, N (i) includes geographic neighbors of region j that precede i in the ordered set V. The precision matrix
where n <i is the number of members in N (i). The above definition of b ij is consistent with the lower-triangular structure of B because j / ∈ N (i) for any j ≥ i. The derivation of B and F as functions of a spatial correlation parameter ρ is based upon forming local autoregressive models on embedded spanning trees of subgraphs of G (13).
A bivariate DAGAR (BDAGAR) model
We now extend the DAGAR to the bivariate case, where we jointly model two cancers across regions. Let w i = (w i1 , w i2 , . . . , w ik ) be the spatial random effect vector for disease i, where w ij refers to the spatial random effect for disease i in region j. We will build a hierarchical model,
where N (· | µ, Q) denotes a normal density with mean µ and precision matrix Q. The precision matrices τ i Q i (ρ i ) for i = 1, 2 are the DAGAR precision matrices formed with the entries of B and F described in [1] with ρ i . Therefore, in [2] we model w 1 as a univariate DAGAR and w 2 conditional on w 1 also as a DAGAR. Each disease has its own distribution and there are two spatial autocorrelation parameters (ρ 1 and ρ 2 ) corresponding to the two diseases. This ensures that spatial associations specific to each disease will be captured.
The matrix A 21 models the association between the two diseases. We use a parametric form
where M is the binary adjacency matrix of the geographic map, i.e., m ij = 1 if i ∼ j and 0 otherwise. The joint
and the covariance matrix Q −1 w is
We call a normal distribution with the above precision, or covariance, matrix, the BDAGAR model. The interpretation of ρ 1 and ρ 2 is clear: ρ 1 measures the spatial association for the first cancer, while ρ 2 is the residual spatial correlation in the second cancer after accounting for the first cancer. Similarly, τ 1 is the spatial precision parameter for the first cancer, while τ 2 is the residual precision for the second cancer after accounting for the first.
Model Implementation
Let y ij be our outcome of interest corresponding to cancer i in region j. We will assume that y ij is a continuous variable, e.g., incidence rates, that is related to a set of explanatory variables through the regression model,
where x ij is a p i ×1 vector of explanatory variables specific to cancer i within region j, β i is the slopes corresponding to cancer i, w ij 's are the spatial effects that collectively follow the bivariate DAGAR distribution described in Section 2.2, and ij ind ∼ N (0, 1/σ 2 i ) capture additional heterogeneity and variability independent of spatial variation, where σ 2 i is the residual variance for cancer i. The regression model is extended to the following specific Bayesian hierarchical framework with the posterior distribution p(β, w, η, ρ, τ, σ | y) proportional to
where β = {β 1 , β 2 }, τ = {τ 1 , τ 2 }, σ = {σ 2 1 , σ 2 2 } and η = {η 0 , η 1 }, and IG(· | a, b) is the inverse-gamma distribution with shape and rate parameters a and b, respectively.
We sample the parameters from the posterior distribution in [6] using Markov chain Monte Carlo (MCMC) with Gibbs sampling and random walk metropolis (25) as implemented in the rjags package within the R statistical computing environment. To compare and assess models, we use the Widely Applicable Information Criterion (WAIC) (26, 27) , which is computed as
where elppd is the expected log point-wise predictive density for a new dataset andp W AIC is the estimated effective number of parameters, which is sum of posterior variance of the log predictive density for each data point. WAIC is easy to compute using posterior samples.
We analyze a data set extracted from the SEER * Stat database using the SEER * Stat statistical software (28) . We consider 2 cancers, lung and esophagus, where the outcome is the crude incidence rates per 100,000 population in the years from 2012 to 2016 across 58 counties in California, USA. County-level explanatory variables for each cancer are available in the same years and include percentages of residents younger than 18 years old (young ij ), older than 65 years old (old ij ), with education level below high school (edu ij ) , percentages of unemployed residents (unemp ij ), black residents (black ij ), male residents (male ij ), uninsured residents (uninsure ij ), and percentages of families below the poverty threshold (poverty ij ).
We analyzed this data set using the Bayesian hierarchical model [6] . The county-level maps of the raw incidence rates per 100,000 population for the two cancers are shown in Figure 1 . The maps exhibit the evidence of correlation across space and between cancers. Cutoffs for the different levels of incidence rates are quantiles for each cancer. For both lung and esophagus cancer, in general, incidence rates are higher in counties located in the northern areas than those in southern part. The four counties in the center including Amador, Calaveras, Tuolumne and Mariposa have relatively high incidence rates compared to the neighboring counties. Overall, counties with similar levels of incidence rates tend to depict some spatial clustering.
For our analysis, we specified the following prior distribution,
where U nif (· | a, b) denotes the Uniform density over (0, 1) and Q w (τ, ρ) is the BDAGAR precision matrix of w given in [3] .
We fit the BDAGAR model using the two different cancer orders, i. itive with a median of 16.27 and 95% credible interval of (10.95, 22.09), while η 1 tends to be positive with a median of 0.87 but with a 95% credible interval (−0.69, 2.43) that includes 0. Consequently, we present the following results and analysis for [lung | esophagus] which seems to be the preferred model. Table 2 summarizes the parameter estimates from the BDAGAR model corresponding to [lung | esophagus]. For fixed effects, the increasing percentage of residents younger than 18 years old significantly reduces the incidence rate for esophagus cancer, while the percentage of residents older than 65 years old has a significantly opposite effect for both esophagus and lung cancer. The increase in the percentage of unemployment also augments the incidence rate of lung cancer significantly. Turning to spatial correlations, ρ 1 measures the residual spatial correlation (posterior mean 0.11)
for esophagus cancer after accounting for the explanatory variables and ρ 2 measures the spatial correlation (posterior mean 0.47) for lung cancer after accounting for the explanatory variables and also the effect of esophagus cancer. The small point estimates and narrower credible interval for ρ 1 indicate greater confidence in weaker spatial correlation for esophagus cancer; the moderate value of ρ 2 and a wider credible interval suggest higher spatial correlation for lung cancer. Turning to the spatial precision of random effects for each cancer, the estimates of {τ 1 , τ 2 } are indicative of esophagus cancer having larger variability, although we must keep in mind that τ 2 is the conditional marginal precision for lung cancer after accounting for esophagus cancer and, therefore, may not be directly comparable to τ 1 . Figure 3 shows the estimated correlation between lung and esophagus cancer in each of 58 counties. This map also seems to be consistent with the estimates of η. Correlations between lung and esophagus cancers in all counties are significantly positive with large means at around 0.97 − 1 which are due to the highly positive values in η 0 . This indicates that esophagus cancer is highly correlated with lung cancer. However, in general, the correlation between the two cancers increases slightly from the center to marginal areas, especially for those with fewer counties in the neighborhood.
Finally, Figure 4 provides further visual corroboration of the goodness of fit for the BDAGAR mode corresponding to [lung | esophagus]. Here, we see that the posterior mean of the incidence rates for lung and esophagus cancer are very consistent with the raw incidence rates shown in Figure 1 . 
Discussion
We have extended a recently proposed class of DAGAR models (13) for univariate disease mapping to bivariate "BDAGAR" models that can be applied to estimate spatial correlations for two correlated cancers. The BDAGAR model retains the interpretation of DAGAR models clearly separating the spatial correlation for each cancer from any inherent or endemic association between the two cancers. The BDAGAR model can still be efficiently computed using MCMC algorithms. Our analysis of incidence rates from lung and esophagus cancer demonstrates the efficiency of BDAGAR and its improved performance, as measured by WAIC, over existing alternatives such as the GMCAR models.
While we have restricted our attention only to cancer incidence rates, BDAGAR models can also be used with timeto-event data to investigate geographical patterns in the hazard function. For example, each patient in a study may provide multiple survival times from the onset of each of two cancers along with his or her county of residence. The BDAGAR model can become an excellent alternative to CAR and different MCAR models in spatial survival analysis (29, 17, 30, 31, 21) .
Spatial Modeling for Correlated Cancers Using Bivariate Directed Graphs
Finally, the BDAGAR models developed here proceeds from conditional specifications. Concerns may arise over the ordering of the variables in the hierarchical approach. While in the case of a few cancers, such as 2 in our case, one can evaluate models arising from the different orders, this strategy will become cumbersome with several cancers.
For instance, even with 4 cancers, we will have 24 different models that will need to be evaluated and compared.
This becomes impractical. A joint modeling approach, analogous to order-free MCAR models as in (20) , can build rich spatial structures from linear transformations of simpler latent variables. For instance, we can develop alternate multivariate DAGAR, or MDAGAR models, using w = Λf , where Λ is a suitably specified square matrix and f is a latent vector whose components follow independent univariate DAGAR distributions. Note that by modeling the joint distribution, the incompatibility of conditional model building (i.e., different joint distributions for different orderings)
is avoided. However, the issue of the identifiability of Λ is raised, and careful specification of its structure is needed.
These approaches will be further investigated elsewhere.
